- Home
- RVSB vs CGTX Comparison
RVSB vs CGTX Comparison
Compare RVSB & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- CGTX
- Stock Information
- Founded
- RVSB 1923
- CGTX 2007
- Country
- RVSB United States
- CGTX United States
- Employees
- RVSB N/A
- CGTX N/A
- Industry
- RVSB Savings Institutions
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- CGTX Health Care
- Exchange
- RVSB Nasdaq
- CGTX Nasdaq
- Market Cap
- RVSB 124.0M
- CGTX 20.5M
- IPO Year
- RVSB 1993
- CGTX 2021
- Fundamental
- Price
- RVSB $5.50
- CGTX $0.30
- Analyst Decision
- RVSB Buy
- CGTX Strong Buy
- Analyst Count
- RVSB 1
- CGTX 5
- Target Price
- RVSB $7.00
- CGTX $5.63
- AVG Volume (30 Days)
- RVSB 258.2K
- CGTX 1.9M
- Earning Date
- RVSB 07-24-2025
- CGTX 08-07-2025
- Dividend Yield
- RVSB 1.45%
- CGTX N/A
- EPS Growth
- RVSB 27.97
- CGTX N/A
- EPS
- RVSB 0.23
- CGTX N/A
- Revenue
- RVSB $50,239,000.00
- CGTX N/A
- Revenue This Year
- RVSB $12.68
- CGTX N/A
- Revenue Next Year
- RVSB $11.53
- CGTX N/A
- P/E Ratio
- RVSB $23.91
- CGTX N/A
- Revenue Growth
- RVSB 3.95
- CGTX N/A
- 52 Week Low
- RVSB $3.30
- CGTX $0.22
- 52 Week High
- RVSB $6.59
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- RVSB 47.03
- CGTX 48.87
- Support Level
- RVSB $5.46
- CGTX $0.25
- Resistance Level
- RVSB $5.65
- CGTX $0.33
- Average True Range (ATR)
- RVSB 0.17
- CGTX 0.03
- MACD
- RVSB 0.03
- CGTX 0.00
- Stochastic Oscillator
- RVSB 51.28
- CGTX 58.69
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.